Improved Cancer Tests Lead to Better Treatments

University of Oklahoma research has introduced a promising strategy for better cancer tests, leading to more effective treatments. The study compares the efficacy of immunohistochemistry (IHC) and next-generation sequencing (NGS) in detecting patients best suited for immunotherapy, with NGS proving superior. This research not only highlights the need for reevaluation of current testing recommendations but also paves the way for a more personalized approach to cancer treatment, ultimately improving patient life quality and making cancer less deadly.